﻿{"id":405,"date":"2010-12-01T00:00:01","date_gmt":"2010-12-01T00:00:01","guid":{"rendered":"https:\/\/awge.doctime.es\/?p=405"},"modified":"2016-05-24T08:21:07","modified_gmt":"2016-05-24T06:21:07","slug":"awge-55","status":"publish","type":"post","link":"https:\/\/awge.doctime.es\/index.php\/2010\/12\/01\/awge-55\/","title":{"rendered":"Efficacy of Intravenous Iron for Treating Postpartum Anemia in Low-Resource African Countries: A Pilot Study in Malawi."},"content":{"rendered":"<div class='editorialPost'><strong>Editorial: J Womens Health <\/strong><\/div>\n<div class='fechaPost'>Fecha: 01\/12\/2010<\/div>\n<div class='autorPost'>Armand-Ug\u00a8\u00aen R, Cheong T, Matapandewu G, Rojo-Sanch\u00a8\u00aas A, Bisbe E, Mu\u00f1oz M; for the Anaemia Working Group Espa\u00f1a.<\/div>\n<div class='enlacePost'><a href='http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21091191' target='_blank'>Acceso al enlace publicador<\/a><\/div>\n<hr>\n<\/hr>\n<div class='resumenPost'>Abstract Background: Postpartum hemorrhage may lead to maternal morbidity and mortality, increases risks of transfusion, and incurs costs. We report on the feasibility and efficacy of in-hospital intravenous (IV) iron for treating postoperative anemia at Mtengo wa Nthenga, Malawi. Patients and methods: Twenty-eight consecutive women undergoing surgery for complicated pregnancy or complicated childbirth entered the study. Patients with hemoglobin (Hb) <10&#8201;g\/dL on postoperative day 1 (n&#8201;=&#8201;14) received IV iron sucrose (200&#8201;mg\/day, 3 consecutive days), and those with Hb \u00a1\u00dd10&#8201;g\/dL (n&#8201;=&#8201;14) received oral iron (ferrous sulfate, 256&#8201;mg\/day). In-hospital postoperative Hb increase and blood transfusion were recorded. Results: Mean changes in Hb from postoperative day 1 to postoperative day 7 were -0.6&#8201;\u00a1\u00c0&#8201;1.2&#8201;g\/dL and 2.1&#8201;\u00a1\u00c0&#8201;1.7&#8201;g\/dL, for the oral and IV iron groups, respectively (p&#8201;=&#8201;0.001). No side effect was seen with IV iron. Only 1 of 4 women receiving allogeneic blood was transfused after the initiation of IV iron treatment. Conclusions: Our results suggest that IV iron sucrose is an effective drug for treating puerperal anemia, leading to a rapid recovery of Hb levels. The current availability of generic iron sucrose preparations, with considerably lower acquisition costs, may facilitate in-hospital access to this treatment option in low-resource countries.\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Editorial: J Womens Health Fecha: 01\/12\/2010 Armand-Ug\u00a8\u00aen R, Cheong T, Matapandewu G, Rojo-Sanch\u00a8\u00aas A, Bisbe E, Mu\u00f1oz M; for the<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[4],"tags":[],"_links":{"self":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts\/405"}],"collection":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/comments?post=405"}],"version-history":[{"count":1,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts\/405\/revisions"}],"predecessor-version":[{"id":671,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/posts\/405\/revisions\/671"}],"wp:attachment":[{"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/media?parent=405"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/categories?post=405"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/awge.doctime.es\/index.php\/wp-json\/wp\/v2\/tags?post=405"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}